Bosnia and Herzegovina

Reimbursed Care Access

Bosnia and Herzegovina retains a restrictive national approach: classic serotonergic psychedelics and entheogenic alkaloids are criminalized and have no routine medical or reimbursed access outside approved research. Ketamine is an established anesthetic available in medical settings, and while it may be used off‑label in clinical practice, there is no evidence of a reimbursed, nationally authorised esketamine (Spravato) program or public reimbursement pathway for psychedelic‑assisted psychiatric indications in Bosnia and Herzegovina.